Combined synopsis and solicitation
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
75F40124Q123021
Food and Drug Administration, FDA Office of Acq Grant SVCS. Biological Product (except Diagnostic) Manufacturing.
Response deadline
May 3, 2024 at 2:00 PM EDT
Closed 868 days ago. Posted April 26, 2024. Scheduled to archive May 18, 2024.
Description
As published on SAM.gov.
See Attached Single Source Combined Synopsis/Solicitation 75F40124Q123021
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
April 26, 2024
Combined synopsis and solicitation
Due May 3, 2024 at 2:00 PM EDT. SAM.gov, notice d07a764db2694beebd2e969a67104c7f
Points of contact
- Howard Nesmithhoward.nesmith@fda.hhs.gov8705437459
Also open from this buyer
- Animal BloodCombined synopsis and solicitationSmall businessNAICS 325414Silver Spring, MDCDRH2026134634Closes todaySep 18
- Rapid Nicotine Pouch Data Analysis ServicesCombined synopsis and solicitationNAICS 541618Silver Spring, MD75F40126Q00407Closes todaySep 18
- Vanquish Neo System and Ion Chromatography systemSolicitationNAICS 33451675F40126Q000430Closes in 3 daysSep 21
- Fourier Transform Infrared Spectrophotometer (FTIR)Combined synopsis and solicitationNAICS 334516San Juan, PR75F40126Q00406Closes in 4 daysSep 22
- 2D High-Density Multi-Electrode Array Electrophysiology PlatformCombined synopsis and solicitationNAICS 334516RFQ_CBER-2026-135968Closes in 5 daysSep 23